The Food and Drug Administration recently notified executives at medical device manufacturer Medtronic that its efforts at rectifying significant issues within its diabetes business are falling short. “In summary,” the agency said, “your corrective actions are still in process, and you have not yet conducted effectiveness checks to ensure the updated procedures and required employee training will prevent reoccurrence of the identified deficiencies.”
The letter comes ...
continue reading...
The metformin recalls that have plagued the diabetes drug industry for the past year continue as yet another company’s formulation of the drug has tested positive for a human carcinogen.
Two lots of diabetes drug metformin produced by Kansas City, Missouri drug maker Nostrum Laboratories are being pulled from pharmacy shelves over concerns that they
Diabetics who take metformin will want to contact their healthcare providers after multiple recalls of the drug have occurred due to the
When the FDA made the decision to give Johnson & Johnson’s diabetes drug